CKB
Creatine kinase B-type
Also known as: CKBB, KCRB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12277
- Gene
- CKB
- Ensembl
- ENSG00000166165
- Chromosome
- 14
- Canonical length
- 381 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a cytoplasmic enzyme involved in energy homeostasis. The encoded protein reversibly catalyzes the transfer of phosphate between ATP and various phosphogens such as creatine phosphate. It acts as a homodimer in brain as well as in other tissues, and as a heterodimer with a similar muscle isozyme in heart. The encoded protein is a member of the ATP:guanido phosphotransferase protein family. A pseudogene of this gene has been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>P12277|CKB
1 MPFSNSHNAL KLRFPAEDEF PDLSAHNNHM AKVLTPELYA ELRAKSTPSG FTLDDVIQTG
61 VDNPGHPYIM TVGCVAGDEE SYEVFKDLFD PIIEDRHGGY KPSDEHKTDL NPDNLQGGDD
121 LDPNYVLSSR VRTGRSIRGF CLPPHCSRGE RRAIEKLAVE ALSSLDGDLA GRYYALKSMT
181 EAEQQQLIDD HFLFDKPVSP LLLASGMARD WPDARGIWHN DNKTFLVWVN EEDHLRVISM
241 QKGGNMKEVF TRFCTGLTQI ETLFKSKDYE FMWNPHLGYI LTCPSNLGTG LRAGVHIKLP
301 NLGKHEKFSE VLKRLRLQKR GTGGVDTAAV GGVFDVSNAD RLGFSEVELV QMVVDGVKLL
361 IEMEQRLEQG QAIDDLMPAQ KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CKB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 1,487 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 1,487 nTPM
- basal ganglia: 1,452 nTPM
- cerebellum: 1,114 nTPM
- colon: 1,026 nTPM
- amygdala: 1,024 nTPM
- midbrain: 868 nTPM
Single-cell type
- colonocytes: 6,346 nCPM
- parietal cells: 5,523 nCPM
- müller glia: 2,585 nCPM
- retinal horizontal cells: 2,350 nCPM
- cone photoreceptor cells: 2,246 nCPM
- rod photoreceptor cells: 1,637 nCPM
Immune cell
- non-classical monocyte: 293 nTPM
- intermediate monocyte: 29 nTPM
- myeloid DC: 16 nTPM
- eosinophil: 15 nTPM
- total PBMC: 6 nTPM
- basophil: 2.4 nTPM
Brain region
- cerebellum: 1,437 nTPM
- basal ganglia: 1,393 nTPM
- cerebral cortex: 1,390 nTPM
- thalamus: 1,359 nTPM
- hypothalamus: 1,104 nTPM
- amygdala: 1,083 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CKB.
Disease | ImmuneIEDB
Conditions an epitope on CKB was assayed in.
- multiple sclerosis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 2.32
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP:guanido phosphotransferase
- Glutamine synthetase/guanido kinase, catalytic domain
- ATP:guanido phosphotransferase, N-terminal
- ATP:guanido phosphotransferase, catalytic domain
- ATP:guanido phosphotransferase active site
- ATP:guanido phosphotransferase, N-terminal domain superfamily
- ATP:guanido phosphotransferase, C-terminal catalytic domain
- ATP:guanido phosphotransferase, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CKB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CKB as an antibody target. Whether an autoantibody or antibody against CKB could matter depends on whether native CKB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CKB is annotated at the cell surface, where native CKB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CKB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...